c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
Calidi Biotherapeutics Reports Third Quarter 2026 Financial Results and Recent Business Highlights
GlobeNewswire Inc. | Nov 13, 2026 5:03 PM EST
- Continued to advance the development of CLD-401 towards the clinic
Read original article